mexiletine has been researched along with Somatoform Disorders in 1 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Once erythromelalgia was suspected clinically, the SCN9A gene was sequenced." | 2.50 | An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder. ( Meijer, IA; Nizard, S; Robitaille, Y; Rossignol, E; Vanasse, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meijer, IA | 1 |
| Vanasse, M | 1 |
| Nizard, S | 1 |
| Robitaille, Y | 1 |
| Rossignol, E | 1 |
1 review available for mexiletine and Somatoform Disorders
| Article | Year |
|---|---|
An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
Topics: Carbamazepine; Child, Preschool; Comorbidity; Erythromelalgia; Female; Humans; Hypesthesia; Mexileti | 2014 |